BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
Home » Authors » John Brosky

John Brosky

Articles

ARTICLES

Scan of heart's magnetic field is revolutionizing diagnosis

Sep. 10, 2008
By John Brosky
MUNICH, Germany — "It's a revolution because it provides information no one has ever seen before from any other cardiac imaging modality," said Torsten Krümmel, CEO and founder of BMDSys (Jena, Germany). (Medical Device Daily)
Read More

High-tech and high-touch tools attract cardiologists

Sep. 9, 2008
By John Brosky
MUNICH, Germany — The one and only exhibition stand for stethoscopes stood out at the European Society of Cardiology (ESC; Sophia Antipolis, France) congress here last week for being the lowest-tech display of products among acres of high-end imaging equipment, but also for the constant queuing up of cardiologists crowding the counter. (Medical Device Daily)
Read More

New bioabsorbable DES holds up in clinical trial

Sep. 5, 2008
By John Brosky

Philips swings at angiography; GE speeds up with Vivid e9

Sep. 5, 2008
By John Brosky

Imaging breakthroughs are 'disrupting' cardiac practice

Sep. 5, 2008
By John Brosky
MUNICH, Germany — The noise and confusion from the bells and whistles being added to cardiology imaging are driving growth and greater revenues for manufacturers, but far more importantly, the steady stream of upgrades and new features is bringing breakthroughs in medical practice. (Medical Device Daily)
Read More

Report from Europe: Report shows 'serious gaps' in British home care efforts

Sep. 4, 2008
By John Brosky

Handheld ultrasound replacing stethoscopes in cardiology

Sep. 4, 2008
By John Brosky
MUNICH, Germany — Cardiologists are users and not direct customers for the big medical imaging companies who sell almost exclusively to radiology departments. (Medical Device Daily)
Read More

Clinical trials, imaging lead busy agenda for cardiologists

Sep. 4, 2008
By John Brosky
MUNICH, Germany — Europe's largest medical conference got under way at the Messe M nchen over the weekend, with in excess of 25,000 physicians attending and another 7,000 industry representatives participating from more than 130 countries. (Diagnostics & Imaging Week)
Read More

DES debate drives demand for better data, tighter standards

Sep. 3, 2008
By John Brosky

Taxus fails to outperform CABG in SYNTAX clinicals

Sep. 3, 2008
By John Brosky
MUNICH, Germany — It was supposed to be a stunning victory for drug-eluting stents (DES). (Medical Device Daily)
Read More
View All Articles by John Brosky

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 30, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 30, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing